Meitheal Pharmaceuticals has Regadenoson Injection Now Available

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Regadenoson Injection, 0.4 mg/5 mL pre-filled syringe.

Meitheal will offer Regadenoson Injection in a carton of 1 syringe.


Regadenoson Injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. For full prescribing information, please click on the following link.


Learn more about who we are and what we do at: